Literature DB >> 25016259

Polymorphism analysis of CTLA-4 in childhood acute lymphoblastic leukemia.

Liang Hui1, Zhang Lei1, Zeng Peng1, Shan Ruobing1, Zhang Fenghua1.   

Abstract

To investigate the correlation between cytotoxic T lymphocyte antigen-4 (CTLA-4) gene polymorphism and children with acute lymphoblastic leukemia (ALL). A total of 86 children of ALL (23 HR, 54SR) and 112 healthy controls was selected. The genptypes were determined by means of polymerase chain reaction (PCR) and the PCR product sequencing. Genotype and alleles frequency of SNP-318, SNP+49 and SNP-CT60 were compares among different groups. The frequency of TC, TT genotype and T allele in ALL children at SNP-318 position were statistically higher than controls. In HR group, the frequency of TC, TT genotype at SNP-318 position was statistically higher than SR group. There was no significantly difference in genotype and allele distribution of SNP+49 position among the HR patients, SR patients and control group. (2) The frequency of GG genotype and G allele in ALL children at SNP-CT60 position were significantly higher than controls. The genotype and allele distribution of SNP-CT60 position between different clinical risk groups were no significantly different. As a result of the increased frequency of TC, TT genotype and T allele at SNP-318, ALL children synthesized more CTLA-4 to deliver the inhibitive signal, and this lead to restraint of T cell activation. Such difference at SNP-318 position was obvious in HR children. The SNP+49 position is probably not the main regulating point in ALL. (2) In SNP-CT60 position, the G allele played the main part. The increase of G allele frequency result in the high expression of CTLA-4. such difference at SNP-318 position was obvious in HR children.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25016259

Source DB:  PubMed          Journal:  Pak J Pharm Sci        ISSN: 1011-601X            Impact factor:   0.684


  6 in total

Review 1.  Immunomodulatory Drugs: Immune Checkpoint Agents in Acute Leukemia.

Authors:  Hanna A Knaus; Christopher G Kanakry; Leo Luznik; Ivana Gojo
Journal:  Curr Drug Targets       Date:  2017       Impact factor: 3.465

2.  Single-Nucleotide Polymorphisms Within Non-HLA Regions Are Associated With Engraftment Effectiveness for Patients With Unrelated Cord Blood Transplantation.

Authors:  Ding-Ping Chen; Tang-Her Jaing; Ai-Ling Hour; Wei-Tzu Lin; Fang-Ping Hsu
Journal:  Front Immunol       Date:  2022-06-13       Impact factor: 8.786

3.  Comprehensive Analysis of 29,464 Cancer Cases and 35,858 Controls to Investigate the Effect of the Cytotoxic T-Lymphocyte Antigen 4 Gene rs231775 A/G Polymorphism on Cancer Risk.

Authors:  Hongyuan Wan; Hangsheng Zhou; Yanyan Feng; Yongquan Chen; Lijie Zhu; Yuanyuan Mi
Journal:  Front Oncol       Date:  2022-05-04       Impact factor: 5.738

4.  Association between the cytotoxic T-lymphocyte antigen 4-318C/T polymorphism and malignant tumor risk.

Authors:  Taiming Li; Chengdi Wang; Zhenju Ren; Y I Ji; Chang Xu; Bing Xiao; Min Liu
Journal:  Biomed Rep       Date:  2016-05-19

5.  Association between CTLA-4 rs231775 polymorphism and hepatocellular carcinoma susceptibility.

Authors:  Zhao Liu; Zhao Song; Jing Sun; Fenglei Sun; Chuanzhi Li; Jiuzheng Sun; Liyou Xu
Journal:  Int J Clin Exp Pathol       Date:  2015-11-01

Review 6.  Immune Checkpoint Molecules-Inherited Variations as Markers for Cancer Risk.

Authors:  Marta Wagner; Monika Jasek; Lidia Karabon
Journal:  Front Immunol       Date:  2021-01-14       Impact factor: 7.561

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.